Analysis of regional differences in the phase 3 METEOR study of cabozantinib (cabo) versus everolimus (eve) in advanced renal cell carcinoma (RCC) Meeting Abstract


Authors: Tannir, N.; Powles, T.; Motzer, R. J.; Rolland, F.; Gravis, G.; Staehler, M.; Rink, M.; Retz, M.; Csoszi, T.; McCaffrey, J.; De Giorgi, U.; Caserta, C.; Cheporov, S.; Gonzalez, E. E.; Duran, I.; Larkin, J. G.; Berg, W.; Clary, D.; Escudier, B.; Choueiri, T. K.
Abstract Title: Analysis of regional differences in the phase 3 METEOR study of cabozantinib (cabo) versus everolimus (eve) in advanced renal cell carcinoma (RCC)
Meeting Title: 41st European Society for Medical Oncology Congress (ESMO)
Journal Title: Annals of Oncology
Volume: 27
Issue: Suppl. 6
Meeting Dates: 2016 Oct 7-11
Meeting Location: Copenhagen, Denmark
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2016-10-01
Start Page: vi285
Language: English
ACCESSION: WOS:000393912500813
DOI: 10.1093/annonc/mdw373.45
PROVIDER: wos
Notes: Meeting Abstract: 818P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer